Structure-based CoMSIA studies on roscovitine derivatives as inhibitors of cyclin-dependent kinases and casein kinase 1

被引：0
|
作者：
Singh, Satyakam [1 ]
Patel, Pallav D. [1 ]
Patel, Maulik R. [1 ]
Kulkarni, Shridhar
Talele, Tanaji T. [1 ]
机构：
[1] St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Jamaica, NY 11439 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
279-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Anticancer agents targeted against cyclin-dependent kinase 2 (CDK2): Structure-based design of irreversible and reversible inhibitors
    Lebraud, Honorine
    Golding, Bernard T.
    Meschini, Elisa
    Cano, Celine
    Anscombe, Elizabeth
    Wang, Lan Z.
    Endicott, Jane A.
    Noble, Martin E. M.
    Newell, David R.
    Griffin, Roger J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [42] Discovery of cyclin-dependent kinase inhibitor, CR229, using structure-based drug screening
    Kim, Min Kyoung
    Min, Jaeki
    Ch, Bu-Young
    Lim, Haeyoung
    Cho, Youl-Hee
    Lee, Chul-Hoon
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 17 (10) : 1712 - 1716
  • [43] 1,7-Annulated indolocarbazoles as cyclin-dependent kinase inhibitors
    Al-Awar, RS
    Ray, JE
    Hecker, KA
    Huang, JP
    Waid, PP
    Shih, CA
    Brooks, HB
    Spencer, CD
    Watkins, SA
    Patel, BR
    Stamm, NB
    Ogg, CA
    Schultz, RM
    Considine, EL
    Faul, MM
    Sullivan, KA
    Kolis, SP
    Grutsch, JL
    Joseph, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (12) : 3217 - 3220
  • [44] BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE
    APRELIKOVA, O
    XIONG, Y
    LIU, ET
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18195 - 18197
  • [45] Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors
    Wang, Fangfang
    Ma, Zhi
    Li, Yan
    Zhu, Shanna
    Xiao, Zhengtao
    Zhang, Hong
    Wang, Yonghua
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2011, 30 : 67 - 81
  • [46] Discovery of novel macrocyclic derivatives as potent and selective cyclin-dependent kinase 2 inhibitors
    Niu, Pengpeng
    Tao, Yanxin
    Meng, Qingyuan
    Huang, Yixing
    Li, Shan
    Ding, Ke
    Ma, Dawei
    Ye, Zu
    Fan, Mengyang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 104
  • [47] Synthesis and Structure of the β-Carboline Derivatives and Their Binding Intensity with Cyclin-Dependent Kinase 2
    Wang, Yue
    Jin, Qiaomei
    Lin, Guowu
    Yang, Taotao
    Wang, Zhanwei
    Lu, Yi
    Tang, Yimin
    Liu, Lifang
    Lu, Tao
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2012, 60 (04) : 435 - 441
  • [48] Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2
    Johnson, LN
    De Moliner, E
    Brown, NR
    Song, HW
    Barford, D
    Endicott, JA
    Noble, MEM
    PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) : 113 - 124
  • [49] Exogenous inhibitors of cyclin-dependent kinases induce the expression of endogenous inhibitor of cyclin-dependent kinase p21waf1/cip1 in prostate cancer cells.
    Silvy, M
    Prévost, GP
    Meijer, L
    Viossat, I
    Thurieau, C
    Calvo, F
    CLINICAL CANCER RESEARCH, 1999, 5 : 3756S - 3756S
  • [50] The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity
    Alessi, F
    Quarta, S
    Savio, M
    Riva, F
    Rossi, L
    Stivala, LA
    Scovassi, AI
    Meijer, L
    Prosperi, E
    EXPERIMENTAL CELL RESEARCH, 1998, 245 (01) : 8 - 18
12345